Vendor review
LP Peptide reviews
LP Peptide reviews from 75 independent lab tests (Retatrutide, Tesamorelin and GHK-Cu): grade A, purity and fill accuracy. Is LP Peptide legit? See what its vials showed.
What the lab tests show
75 tests on record, newest first. Scores are purity divided by ten.
| Date | Product | Purity | Quantity | Identity | Certificate |
|---|---|---|---|---|---|
| Oct 12, 2026 | Tesamorelin | 99.8 % | 13.4 mg of 10 mg (34 %) | Pass | View |
| Oct 9, 2026 | Retatrutide | 5 mg | Fail | View | |
| Oct 8, 2026 | Retatrutide | 30 mg | Fail | View | |
| Oct 8, 2026 | Tesamorelin | 99.8 % | 10.3 mg of 10 mg (3 %) | Pass | View |
| Oct 8, 2026 | Tirzepatide | 30 mg | Fail | View | |
| Oct 1, 2026 | Tirzepatide | 30 mg | Fail | View | |
| Oct 1, 2026 | NAD+ | 94.3 % | 787 mg of 1000 mg (-21 %) | Pass | View |
| Sep 30, 2026 | Retatrutide | 99.99 % | 27.16 mg of 30 mg (-9 %) | Pass | View |
| Sep 30, 2026 | Retatrutide | 99.9 % | 29.99 mg of 30 mg (0 %) | Pass | View |
| Sep 30, 2026 | Retatrutide | 99.9 % | 19.99 mg of 20 mg (0 %) | Pass | View |
| Sep 29, 2026 | Tirzepatide | 99.99 % | 10.22 mg of 10 mg (2 %) | Pass | View |
| Sep 25, 2026 | Tirzepatide | 30 mg | Fail | View | |
| Sep 25, 2026 | Retatrutide | 99.9 % | 9.99 mg of 10 mg (0 %) | Pass | View |
| Sep 25, 2026 | Retatrutide | 99.9 % | 29.99 mg of 30 mg (0 %) | Pass | View |
| Sep 25, 2026 | Tesamorelin | 99.9 % | 8.35 mg of 10 mg (-17 %) | Pass | View |
| Sep 25, 2026 | GHK-Cu | 99.9 % | 49.99 mg of 50 mg (0 %) | Pass | View |
| Sep 24, 2026 | Retatrutide | 99.9 % | 27.2 mg of 30 mg (-9 %) | Pass | View |
| Sep 24, 2026 | Retatrutide | 30 mg | Fail | View | |
| Sep 24, 2026 | Retatrutide | 10 mg | Fail | View | |
| Sep 24, 2026 | BPC-157 | 99.9 % | 10.7 mg of 10 mg (7 %) | Pass | View |
| Sep 18, 2026 | Retatrutide | 99.9 % | 8.43 mg of 10 mg (-16 %) | Pass | View |
| Sep 18, 2026 | Tesamorelin | 99.9 % | 5.24 mg of 10 mg (-48 %) | Pass | View |
| Sep 16, 2026 | Retatrutide | 99.9 % | 40.2 mg of 30 mg (34 %) | Pass | View |
| Sep 16, 2026 | Tirzepatide | 15 mg | Fail | View | |
| Sep 10, 2026 | Tirzepatide | 65.4 % | 19.7 mg of 30 mg (-34 %) | Pass | View |
| Sep 9, 2026 | Retatrutide | 99.9 % | 8.61 mg of 10 mg (-14 %) | Pass | View |
| Sep 9, 2026 | GHK-Cu | 99.9 % | 13.1 mg of 100 mg (-87 %) | Pass | View |
| Sep 9, 2026 | Retatrutide | 20 mg | Fail | View | |
| Sep 9, 2026 | Retatrutide | 20 mg | Fail | View | |
| Sep 9, 2026 | CJC-1295 | 10 mg | Fail | View | |
| Sep 5, 2026 | GHK-Cu | 99.7 % | 56.5 mg of 50 mg (13 %) | Pass | View |
| Sep 4, 2026 | Tirzepatide | 99.9 % | 26.4 mg of 30 mg (-12 %) | Pass | View |
| Aug 25, 2026 | Tesamorelin | 99.7 % | 12.4 mg of 10 mg (24 %) | Pass | View |
| Aug 25, 2026 | GHK-Cu | 99.7 % | 72.1 mg of 100 mg (-28 %) | Pass | View |
| Aug 20, 2026 | Retatrutide | 60 mg | Fail | View | |
| Aug 18, 2026 | BPC-157 | 99.6 % | 10 mg of 10 mg (0 %) | Pass | View |
| Aug 15, 2026 | GHK-Cu | 99.7 % | 53 mg of 50 mg (6 %) | Pass | View |
| Aug 13, 2026 | Retatrutide | 99.8 % | 30.6 mg of 30 mg (2 %) | Pass | View |
| Aug 9, 2026 | Retatrutide | 99.8 % | 10.4 mg of 10 mg (4 %) | Pass | View |
| Aug 9, 2026 | Retatrutide | 99.7 % | 9.8 mg of 10 mg (-2 %) | Pass | View |
| Aug 9, 2026 | Tirzepatide | 99.8 % | 34.2 mg of 30 mg (14 %) | Pass | View |
| Aug 6, 2026 | Retatrutide | 20 mg | Fail | View | |
| Aug 6, 2026 | Retatrutide | 10 mg | View | ||
| Aug 3, 2026 | BPC-157 | 99.2 % | 4.69 mg of 5 mg (-6 %) | Pass | View |
| Aug 3, 2026 | Retatrutide | 99.9 % | 8.61 mg of 10 mg (-14 %) | Pass | View |
| Aug 3, 2026 | Retatrutide | 99.9 % | 18 mg of 20 mg (-10 %) | Pass | View |
| Jul 30, 2026 | Tesamorelin | 10 mg | Fail | View | |
| Jul 30, 2026 | Tesamorelin | 5 mg | Fail | View | |
| Jul 23, 2026 | NAD+ | 1000 mg | Fail | View | |
| Jul 23, 2026 | GHK-Cu | 99.9 % | 12.9 mg of 100 mg (-87 %) | Pass | View |
| Jul 20, 2026 | Retatrutide | 99.9 % | 8.09 mg of 10 mg (-19 %) | Pass | View |
| Jul 20, 2026 | GHK-Cu | 99.7 % | 71 mg of 100 mg (-29 %) | Pass | View |
| Jul 20, 2026 | Tesamorelin | 5 mg | Fail | View | |
| Jul 17, 2026 | Retatrutide | 20 mg | Fail | View | |
| Jul 14, 2026 | Retatrutide | 30 mg | Fail | View | |
| Jul 14, 2026 | Tesamorelin | 99.2 % | 10.1 mg of 10 mg (1 %) | Pass | View |
| Jul 14, 2026 | BPC-157 | 10 mg | Fail | View | |
| Jul 14, 2026 | CJC-1295 | 10 mg | Fail | View | |
| Jul 13, 2026 | Retatrutide | 20 mg | Fail | View | |
| Jul 13, 2026 | Retatrutide | 15 mg | Fail | View |
What LP Peptide sells
No current listings on record.
About LP Peptide
Finnrick has tested 75 samples from LP Peptide across 7 products.